Inventor
CHAI WENYING
US31 patents
⚠️ This page may combine multiple inventors who share the name “CHAI WENYING”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
JANSSEN PHARMACEUTICA NV
22 patentsUS9079911B2Jul 14, 2015
Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators
JANSSEN PHARMACEUTICA NV13 citations92
US11059828B2Jul 13, 2021
Disubstituted octahydropyrrolo[3,4-C]pyrroles as orexin receptor modulators
JANSSEN PHARMACEUTICA NV3 citations83
US10981911B2Apr 20, 2021
Imidazopyrrolopyridine as inhibitors of the JAK family of kinases
JANSSEN PHARMACEUTICA NV6 citations83
US11827638B2Nov 28, 2023
Imidazopyrrolopyridine as inhibitors of the JAK family of kinases
JANSSEN PHARMACEUTICA NV2 citations72
US11667644B2Jun 6, 2023
Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators
JANSSEN PHARMACEUTICA NV2 citations72
USRE48841EDec 7, 2021
Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators
JANSSEN PHARMACEUTICA NV2 citations72
US9265770B2Feb 23, 2016
1,2,5-substituted benzimidazoles as FLAP modulators
JANSSEN PHARMACEUTICA NV3 citations72
US8952177B2Feb 10, 2015
1,2,6-substituted benzimidazoles as FLAP modulators
JANSSEN PHARMACEUTICA NV4 citations72
US10947252B2Mar 16, 2021
Inhibitors of KEAP1-Nrf2 protein-protein interaction
JANSSEN PHARMACEUTICA NV3 citations71
US11254673B2Feb 22, 2022
Small molecule inhibitors of NF-κB inducing kinase
JANSSEN PHARMACEUTICA NV2 citations69
US12378254B2Aug 5, 2025
Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators
JANSSEN PHARMACEUTICA NV0 citations62
US9089569B2Jul 28, 2015
1,2,6-substituted benzimidazoles as flap modulators
JANSSEN PHARMACEUTICA NV3 citations62
US9067917B2Jun 30, 2015
1,2,5-substituted benzimidazoles as FLAP modulators
JANSSEN PHARMACEUTICA NV3 citations61
US7402680B2Jul 22, 2008
Fused heterocyclic compounds
JANSSEN PHARMACEUTICA NV4 citations61
US11897900B2Feb 13, 2024
Inhibitors of KEAP1-Nrf2 protein-protein interaction
JANSSEN PHARMACEUTICA NV0 citations60
US11427601B1Aug 30, 2022
Inhibitors of KEAP1-Nrf2 protein-protein interaction
JANSSEN PHARMACEUTICA NV0 citations60
US9695149B2Jul 4, 2017
1,2,6-substituted benzimidazoles as flap modulators
JANSSEN PHARMACEUTICA NV0 citations51
US9682971B2Jun 20, 2017
1,2,5-Substituted benzimidazoles as flap modulators
JANSSEN PHARMACEUTICA NV0 citations51
US7897771B2Mar 1, 2011
Fused heterocyclic compounds
JANSSEN PHARMACEUTICA NV0 citations51
US9682972B2Jun 20, 2017
1,2,5-substituted benzimidazoles as flap modulators
JANSSEN PHARMACEUTICA NV0 citations49
US9981909B2May 29, 2018
Serotonin receptor modulators
JANSSEN PHARMACEUTICA NV0 citations48
US10172856B2Jan 8, 2019
2,4-diaminopyrimidine derivatives as histamine H4 modulators
JANSSEN PHARMACEUTICA NV0 citations41
ORTHO MCNEIL PHARM INC
4 patentsUS6803362B2Oct 12, 2004
Heterocyclic compounds
ORTHO MCNEIL PHARM INC38 citations91
US6288235B1Sep 11, 2001
Methods for the synthesis of highly substituted 2,4-dioxopiperidine libraries
ORTHO MCNEIL PHARM INC2 citations63
US6872834B2Mar 29, 2005
Phenyl-substituted indoles and indazoles
ORTHO MCNEIL PHARM INC0 citations52
US6686503B2Feb 3, 2004
Methods for the synthesis of highly substituted 2,4-dioxopiperidine libraries
ORTHO MCNEIL PHARM INC0 citations52